User profiles for Mark Jit

Mark Jit

Professor, London School of Hygiene & Tropical Medicine
Verified email at lshtm.ac.uk
Cited by 31149

Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis

…, M Drolet, MC Boily, EL Franco, M Jit… - The Lancet infectious …, 2012 - thelancet.com
Background The extent of cross-protection is a key element in the choice of human
papillomavirus (HPV) vaccine to use in vaccination programmes. We compared the cross-protective …

[HTML][HTML] Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts

…, N Davies, Y Liu, S Clifford, P Klepac, M Jit… - The Lancet Global …, 2020 - thelancet.com
Background Isolation of cases and contact tracing is used to control outbreaks of infectious
diseases, and has been used for coronavirus disease 2019 (COVID-19). Whether this …

[HTML][HTML] Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study

A Clark, M Jit, C Warren-Gash, B Guthrie… - The Lancet Global …, 2020 - thelancet.com
Background The risk of severe COVID-19 if an individual becomes infected is known to be
higher in older individuals and those with underlying health conditions. Understanding the …

[HTML][HTML] Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle …

…, M Caruana, DTN Nguyen, MA Smith, JF Laprise, M Jit… - The Lancet, 2020 - thelancet.com
Background The WHO Director-General has issued a call for action to eliminate cervical
cancer as a public health problem. To help inform global efforts, we modelled potential human …

Economic evaluation of human papillomavirus vaccination in the United Kingdom

M Jit, YH Choi, WJ Edmunds - Bmj, 2008 - bmj.com
Objective To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls
against human papillomavirus infection in the United Kingdom. Design Economic evaluation. …

Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation

M Baguelin, AJ Van Hoek, M Jit, S Flasche, PJ White… - Vaccine, 2010 - Elsevier
Decisions on how to mitigate an evolving pandemic are technically challenging. We present
a real-time assessment of the effectiveness and cost-effectiveness of alternative influenza A/…

[HTML][HTML] Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

…, AJ Pollard, HJ Larson, Y Teerawattananon, M Jit - The Lancet, 2021 - thelancet.com
The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that
protect against severe disease and preferably drive herd immunity. Regulators in numerous …

[HTML][HTML] COVID-19 vaccine challenges: What have we learned so far and what remains to be done?

R Forman, S Shah, P Jeurissen, M Jit, E Mossialos - Health policy, 2021 - Elsevier
Abstracts Developing and distributing a safe and effective SARS-CoV-2 (COVID-19) vaccine
has garnered immense global interest. Less than a year after COVID-19 was declared a …

[HTML][HTML] Social contacts and mixing patterns relevant to the spread of infectious diseases

J Mossong, N Hens, M Jit, P Beutels, K Auranen… - PLoS …, 2008 - journals.plos.org
Background Mathematical modelling of infectious diseases transmitted by the respiratory or
close-contact route (eg, pandemic influenza) is increasingly being used to determine the …

Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England

…, K Diaz-Ordaz, R Keogh, RM Eggo, S Funk, M Jit… - Science, 2021 - science.org
INTRODUCTION Several novel variants of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), the virus that causes COVID-19, emerged in late 2020. One of these, …